Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antidepressant monoamine oxidase inhibitor |
| gptkbp:ATCCode |
N06AF02
|
| gptkbp:brand |
gptkb:Marplan
|
| gptkbp:CASNumber |
59-63-2
|
| gptkbp:contains_functional_group |
gptkb:isoxazole
hydrazide |
| gptkbp:contraindication |
gptkb:pheochromocytoma
concurrent use with SSRIs |
| gptkbp:discoveredBy |
gptkb:Hoffmann-La_Roche
|
| gptkbp:eliminationHalfLife |
2-4 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C12H13N3O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
Isocarboxazid
|
| gptkbp:introducedIn |
1950s
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:MeSH_ID |
D007566
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
3630
3760 CHEMBL1201 DB01170 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
insomnia dry mouth hypertensive crisis |
| gptkbp:UNII |
Q60VQ85798
|
| gptkbp:usedFor |
treatment of depression
|
| gptkbp:bfsParent |
gptkb:Antidepressants
|
| gptkbp:bfsLayer |
6
|